BR112012025486A2 - peptídeos cluap1 e vacinas incluindo os mesmos - Google Patents

peptídeos cluap1 e vacinas incluindo os mesmos

Info

Publication number
BR112012025486A2
BR112012025486A2 BR112012025486A BR112012025486A BR112012025486A2 BR 112012025486 A2 BR112012025486 A2 BR 112012025486A2 BR 112012025486 A BR112012025486 A BR 112012025486A BR 112012025486 A BR112012025486 A BR 112012025486A BR 112012025486 A2 BR112012025486 A2 BR 112012025486A2
Authority
BR
Brazil
Prior art keywords
cluap1
peptides
same
vaccines including
vaccines
Prior art date
Application number
BR112012025486A
Other languages
English (en)
Portuguese (pt)
Inventor
Ryuji Ohsawa
Sachiko Yoshimura
Takuya Tsunoda
Tomohisa Watanabe
Yusuke Nakamura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of BR112012025486A2 publication Critical patent/BR112012025486A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112012025486A 2010-04-08 2010-10-26 peptídeos cluap1 e vacinas incluindo os mesmos BR112012025486A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32209910P 2010-04-08 2010-04-08
PCT/JP2010/006313 WO2011125139A1 (fr) 2010-04-08 2010-10-26 Peptides cluap1 et vaccins les comprenant

Publications (1)

Publication Number Publication Date
BR112012025486A2 true BR112012025486A2 (pt) 2017-01-10

Family

ID=44762128

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012025486A BR112012025486A2 (pt) 2010-04-08 2010-10-26 peptídeos cluap1 e vacinas incluindo os mesmos

Country Status (9)

Country Link
JP (1) JP2013523083A (fr)
KR (1) KR20130043632A (fr)
AU (1) AU2010350389A1 (fr)
BR (1) BR112012025486A2 (fr)
CA (1) CA2795423A1 (fr)
MX (1) MX2012011666A (fr)
SG (1) SG184468A1 (fr)
TW (1) TW201134480A (fr)
WO (1) WO2011125139A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2267021T3 (en) * 2002-09-12 2015-03-30 Oncotherapy Science Inc KDR peptides and vaccines comprising the same
TW201000115A (en) * 2008-06-11 2010-01-01 Oncotherapy Science Inc IQGAP3 epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
JP2013523083A (ja) 2013-06-17
MX2012011666A (es) 2012-12-17
CA2795423A1 (fr) 2011-10-13
TW201134480A (en) 2011-10-16
KR20130043632A (ko) 2013-04-30
AU2010350389A1 (en) 2012-10-25
WO2011125139A1 (fr) 2011-10-13
SG184468A1 (en) 2012-11-29

Similar Documents

Publication Publication Date Title
BR112013010834A2 (pt) polipeptídeos fator ix modificados e usos dos mesmos
UY34254A (es) Proteínas y péptidos modificados.
DK2920197T3 (da) Prolinlåste sammenhæftede peptider og anvendelser deraf
BR112015001211A2 (pt) novos ácidos 5-aminotetra-hidroquinolina-2-carboxílicos e sua utilização
BR112013013663A2 (pt) ácidos 1-benzilcicloalquilcarboxílicos substituídos e sua utilização
EA201390254A1 (ru) Модифицированные полипептиды релаксина и их применение
DK3027564T3 (da) Nedsænket forbrændingssmelter og fremgangsmåde
BRPI0914782A2 (pt) peptídeos de epítopos de cdca1 e vacinas contendo os mesmos
BRPI1008887A2 (pt) peptídeos de foxm1 e vacinas contendo os mesmo
BR112013028251A2 (pt) polipeptídeo
BRPI1009301A2 (pt) peptídeos neil 3 e vacinas incluindo os mesmos
HK1251236A1 (zh) Topk肽和包含它們的疫苗
BR112013024562A2 (pt) fios de fibra de vidro e produtos reforçados compreendendo os mesmos
BR112014000256A2 (pt) formulação de microemulsões transparentes e nutritivas
EP3049153B8 (fr) Peptides cycliques se liant aux bêta-amyloïdes et leur utilisation
BRPI1010666A2 (pt) peptídeos de cdc45l e vacinas incluindo dos mesmos
BR112013013158A2 (pt) peptídeos de tomm34 e vacinas incluindo os mesmos
BRPI1013938A2 (pt) "peptídeos ttk e vacinas incluindo os mesmos"
BRPI1012312A2 (pt) peptídeos vangl1 e vacinas incluindo os mesmos
BRPI0923402A2 (pt) Peptídeos c10rf59 e vacinas incluindo os mesmos.
BRPI1013384A2 (pt) peptídeos c6orf167 e vacinas incluindo os mesmos
ZA201207342B (en) Ect2 peptides and vaccines including the same
IL221474A0 (en) Hjurp peptides and vaccines including the same
IL225552A0 (en) wdhd1 peptides and vaccines containing them
BR112013027390A2 (pt) formulação farmacêutica

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]